We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cord Blood America Updates Investors on China and Las Vegas Operations PR Newswire LAS VEGAS, May 4 LAS VEGAS, May 4 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI...
Cord Blood America's CEO Matthew Schissler, In Analyst Interview, Discusses China Expansion PR Newswire LAS VEGAS, April 1 LAS VEGAS, April 1 /PRNewswire-FirstCall/ -- Cord Blood America, Inc...
Cord Blood America Signs License Agreement to Operate Stem Cell Collection Business in China PR Newswire LAS VEGAS, March 31 LAS VEGAS, March 31 /PRNewswire-FirstCall/ -- Cord Blood America, Inc...
AXM Pharma (OTC: AXMP) announced today that it has entered into an agreement with Beida Wei Ming Bioproduct Co., Ltd. (?Beida Wei?) under which Beida Wei will invest $2.65...
AXM Pharma Inc. (OTC: AXMP) a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that...
AXM Pharma, Inc. (OTC: AXMP), a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that it has appointed...
AXM Pharma, Inc. (OTC: AXMP), a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that it has completed the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 1000 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 333 | 1.0E-6 | CS |
52 | -9.0E-6 | -90 | 1.0E-5 | 1.0E-5 | 1.0E-6 | 663 | 1.51E-6 | CS |
156 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 24116 | 8.495E-5 | CS |
260 | -0.000499 | -99.8 | 0.0005 | 0.04 | 1.0E-6 | 27098 | 0.00098656 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions